君实生物-U
(688180)
| 流通市值：219.43亿 | | | 总市值：282.89亿 |
| 流通股本：7.65亿 | | | 总股本：9.86亿 |
| 报告期 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,502,201,285.66 | 2,474,595,086.04 | 2,711,730,023.03 | 4,559,310,225.4 |
| 应收票据及应收账款 | 509,816,712.45 | 466,688,600.66 | 449,904,393.75 | 492,079,830.03 |
| 应收账款 | 509,816,712.45 | 466,688,600.66 | 449,904,393.75 | 492,079,830.03 |
| 预付款项 | 199,787,005.7 | 283,147,433.17 | 267,236,638.39 | 230,651,220.12 |
| 其他应收款合计 | 36,441,479.37 | 201,570,630.64 | 201,787,961.6 | 230,539,201.08 |
| 存货 | 584,470,922.86 | 567,442,634.42 | 554,106,579.98 | 535,548,261.19 |
| 一年内到期的非流动资产 | 2,187,306.15 | 4,746,758.42 | 9,336,705.99 | 7,281,781.08 |
| 其他流动资产 | 18,404,148.29 | 17,334,532.51 | 26,794,605.6 | 138,415,855.49 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 4,283,817,107.05 | 4,585,525,675.86 | 4,820,896,908.34 | 6,193,826,374.39 |
| 非流动资产: | | | | |
| 长期股权投资 | 223,334,442.32 | 228,455,933.85 | 293,584,434.64 | 268,963,219.78 |
| 其他权益工具投资 | 62,565,091.14 | 43,570,437.54 | 56,134,213.7 | 84,286,167.24 |
| 其他非流动金融资产 | 940,504,669.94 | 825,298,707.07 | 799,204,148.37 | 830,197,164.28 |
| 固定资产 | 2,281,061,188.57 | 2,315,877,222.08 | 2,363,540,377.29 | 2,372,286,903.44 |
| 在建工程 | 1,858,563,731.17 | 1,693,261,195.29 | 1,525,473,513.14 | 1,394,149,750.11 |
| 使用权资产 | 55,598,802.53 | 50,607,736.54 | 30,215,309.8 | 43,355,616.28 |
| 无形资产 | 521,405,365.27 | 526,498,411.05 | 533,024,609.63 | 540,298,227.16 |
| 长期待摊费用 | 6,120,035.12 | 8,015,516.26 | 10,815,836.49 | 9,922,161.54 |
| 递延所得税资产 | 87,045,275.35 | 103,204,370.54 | 102,228,141.29 | 100,552,719.5 |
| 其他非流动资产 | 461,944,701.64 | 477,298,318.62 | 453,895,968.92 | 186,647,492.77 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 6,498,143,303.05 | 6,272,087,848.84 | 6,168,116,553.27 | 5,830,659,422.1 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 10,781,960,410.1 | 10,857,613,524.7 | 10,989,013,461.61 | 12,024,485,796.49 |
| 流动负债: | | | | |
| 短期借款 | 678,106,154.4 | 631,656,782.41 | 667,173,900.12 | 1,232,834,604.87 |
| 应付票据及应付账款 | 1,232,683,826.19 | 984,192,219.84 | 1,029,956,459.95 | 1,120,159,848.07 |
| 其中：应付票据 | - | - | - | 4,672,296.11 |
| 应付账款 | 1,232,683,826.19 | 984,192,219.84 | 1,029,956,459.95 | 1,115,487,551.96 |
| 合同负债 | 8,165,732.53 | 162,981,528.94 | 154,278,073.67 | 146,445,313.65 |
| 应付职工薪酬 | 252,681,242.49 | 232,595,559.68 | 191,851,117.58 | 258,227,042.23 |
| 应交税费 | 39,575,276.61 | 35,574,827.08 | 36,307,882.2 | 29,650,289.64 |
| 其他应付款合计 | 35,768,048.63 | 36,180,635.11 | 43,640,269.58 | 50,405,150.42 |
| 一年内到期的非流动负债 | 246,789,095.44 | 213,788,135.65 | 154,434,228.4 | 122,109,930.8 |
| 其他流动负债 | 154,453.34 | 617.73 | 8,563,217.12 | 8,540,844.7 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 2,493,923,829.63 | 2,296,970,306.44 | 2,286,205,148.62 | 2,968,373,024.38 |
| 非流动负债: | | | | |
| 长期借款 | 1,979,680,277.34 | 1,905,722,659.97 | 1,738,309,662.32 | 1,659,145,050.57 |
| 租赁负债 | 26,313,075.5 | 24,796,059.18 | 9,519,959.85 | 15,315,395.06 |
| 预计负债 | 9,566,615.01 | 17,624,701.47 | 17,624,701.47 | 20,471,714.7 |
| 递延收益 | 181,913,109.58 | 175,543,917.69 | 177,199,159.48 | 180,918,412.77 |
| 其他非流动负债 | 158,433,738.89 | 157,015,405.56 | 155,597,072.22 | 161,448,000.48 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 2,355,906,816.32 | 2,280,702,743.87 | 2,098,250,555.34 | 2,037,298,573.58 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 4,849,830,645.95 | 4,577,673,050.31 | 4,384,455,703.96 | 5,005,671,597.96 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 985,689,871 | 985,689,871 | 985,689,871 | 985,689,871 |
| 资本公积 | 15,406,557,142.12 | 15,394,559,338.2 | 15,394,559,338.2 | 15,394,559,338.2 |
| 减:库存股 | 30,892,473.08 | 30,892,473.08 | 30,892,473.08 | 29,892,175.95 |
| 其他综合收益 | -159,937,004.34 | -190,011,657.5 | -166,409,457.44 | -141,214,389.72 |
| 未分配利润 | -10,340,993,199.41 | -9,986,835,322.23 | -9,705,021,448.29 | -9,343,095,847.81 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 5,860,424,336.29 | 6,172,509,756.39 | 6,477,925,830.39 | 6,866,046,795.72 |
| 少数股东权益 | 71,705,427.86 | 107,430,718 | 126,631,927.26 | 152,767,402.81 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 5,932,129,764.15 | 6,279,940,474.39 | 6,604,557,757.65 | 7,018,814,198.53 |
| 负债和股东权益合计 | 10,781,960,410.1 | 10,857,613,524.7 | 10,989,013,461.61 | 12,024,485,796.49 |
| 公告日期 | 2025-03-28 | 2024-10-30 | 2024-08-31 | 2024-04-30 |
| 审计意见(境内) | 标准无保留意见 | | | |